Skip to main content
. 2018 Apr 20;9(19):4529–4534. doi: 10.1039/c8sc00609a

Scheme 3. Late-stage modification of biologically active molecules. aOxalate 1a (2.0 equiv.), 20 mol% NiBr2, 45 °C. b20 mol% NiBr2, 45 °C. c20 mol% NiBr2.

Scheme 3